发明名称 |
MEDICAMENT INCLUDING ANTI-Fas ANTIBODY |
摘要 |
PROBLEM TO BE SOLVED: To prepare a medicament capable of inducing apoptosis and helpful for the therapy of diseases due to the abnormality of an Fas/Fas ligand system by including a molecule having an antigen-binding region specific to an epitope preserved among Fas's of (non-)primates as an active principle. SOLUTION: This medicament is prepared by including a molecule such as a heavy chain polypeptide of formula I (wherein, FRH1 has 18-30 amino acids; CDRH1 is an amino acid sequence of formula II; FRH2 has 14 amino acids; CDRH2 is an amino acid sequence of formula III ; FRH3 has 32 amino acids; CDRH3 is an amino acid sequence of formula IV; FRH4 has 11 amino acids) or a light chain polypeptide of formula V (wherein, FRL1 has 23 amino acids; CDRLI is an amino acid sequence of formula VI; FRL2 has 15 amino acids; CDRL2 is an amino acid sequence of formula VII; FRL3 has 32 amino acids; CDRL3 is an amino acid sequence of formula WIII; FRL4 has 10 amino acids) respectively having an antigen-binding region specific to an epitope preserved among Fas's of primates such as a human and non-primates as an active principle. |
申请公布号 |
JP2000169393(A) |
申请公布日期 |
2000.06.20 |
申请号 |
JP19990278301 |
申请日期 |
1999.09.30 |
申请人 |
SANKYO CO LTD |
发明人 |
SERIZAWA NOBUKI;HARUYAMA HIDEYUKI;TAKAHASHI WATARU;KODA HIROKO;ICHIKAWA KIMIHISA;OSUMI JUN;OTSUKI MASAHIKO;SHIRAISHI AKIO;YONEHARA SHIN |
分类号 |
C12N15/02;A61K39/00;A61K39/395;A61P1/16;A61P7/06;A61P9/00;A61P9/10;A61P13/12;A61P31/18;A61P37/06;C07K16/28;C12N5/10;C12N15/09;C12P21/08 |
主分类号 |
C12N15/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|